Discover how our expert team supported a major pharmaceutical company in navigating a complex global regulatory scenario involving two distinct registration strategies for the same medicinal product across Europe and the United States.
Asphalion provided comprehensive strategic and operational regulatory support, leveraging an already approved EU dossier in therapeutic indication 1 while guiding the development of a separate submission pathway for the US, where the product had not yet been authorized.
If you require any assistance, contact us at: [email protected]
Download here:
Share
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
